Alzinova: Completes Preclinical Humanization of ALZ-201
Research Note
2022-01-21
10:00
Redeye is encouraged by the news that Alzinova has successfully completed the humanization work, and selected a humanized lead candidate, of its monoclonal antibody ALZ-201.
KS
Kevin Sule
Disclosures and disclaimers